Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 1.000 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.537 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.535 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.494 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.489 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.484 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.466 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.462 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.460 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.458 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
4j98 | ACP | Fibroblast growth factor receptor 2 | / | 0.456 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.454 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.453 | |
4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.453 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.452 | |
3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.451 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.447 | |
3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.444 | |
3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.442 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.441 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.440 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.440 |